mortality/aging
• mice exhibit reduced longevity, with reduced survival beginning around 20 weeks of age
|
growth/size/body
• eccentric hypertrophy
|
• males exhibit facial dysmorphia
|
• increase in nasal bone width
|
• males exhibit decreased weight
|
craniofacial
• shorter skull length in males
|
• increase in skull width
|
• decrease in parietal bone length
|
• males exhibit facial dysmorphia
|
• increase in nasal bone width
|
cardiovascular system
• increase in cardiomyocyte area
|
• eccentric hypertrophy
|
• increase in stroke volume in females
|
• decrease in % ejection fraction and fractional shortening in males
|
• echocardiography indicates decreased left ventricular systolic function and increased diastolic dimensions
|
cellular
• MEFs exhibit increased growth rate
|
muscle
• increase in cardiomyocyte area
|
• decrease in % ejection fraction and fractional shortening in males
|
skeleton
• shorter skull length in males
|
• increase in skull width
|
• decrease in parietal bone length
|
• increase in nasal bone width
|
respiratory system
• increase in nasal bone width
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Noonan syndrome 10 | DOID:0060588 |
OMIM:616564 |
J:268690 |